Detalles de la búsqueda
1.
[Risk assessment of drugs during breastfeeding]. / Évaluation des risques liés aux médicaments pendant l'allaitement.
Rev Med Suisse
; 19(846): 1940-1947, 2023 Oct 18.
Artículo
en Francés
| MEDLINE | ID: mdl-37850807
2.
Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.
Support Care Cancer
; 30(5): 3655-3659, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34993650
3.
Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.
Ther Drug Monit
; 42(1): 33-44, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31479043
4.
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.
PLoS One
; 19(6): e0304573, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38848380
5.
Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project.
Expert Opin Drug Metab Toxicol
; 19(5): 269-283, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269321
6.
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project.
Therapie
; 78(2): 149-156, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36804048
7.
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
Cancers (Basel)
; 15(1)2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612312
8.
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Front Psychiatry
; 14: 1167870, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37275991
9.
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Pharmaceutics
; 14(7)2022 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35890213
10.
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
Pharmaceutics
; 14(9)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36145591
11.
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.
JMIR Res Protoc
; 10(6): e30090, 2021 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185020
12.
Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.
Clin Pharmacokinet
; 57(1): 1-6, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28634655
13.
Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1083: 124-136, 2018 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544202
14.
Therapeutic drug monitoring of targeted anticancer therapy.
Biomark Med
; 9(9): 887-93, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26333311
15.
[Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs]. / Suivi thérapeutique pharmacologique à la 4e journée de pharmacologie des anti-tumoraux.
Bull Cancer
; 104(9): 800-806, 2017 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-28756867
Resultados
1 -
15
de 15
1
Próxima >
>>